Average annual interest rate on mortgage loans in USD increased by 0.3 in December to 13%

YEREVAN, February 9. /ARKA/. The average annual interest rate on mortgage loans in USD increased by 0.3% in 2011 December as opposed to November to 13%, according to a  Central Bank of Armenia report. The average interest rate on loans in Armenian national currency fell by 0.1 percentage points to 12.7%.

The average interest rate on long-term loans in AMD, issued by commercial banks  decreased by 0.6 percentage points in December to 17% and the interest rate on loans in foreign currency increased by 0.3% to 13.4%.

Short-term loans in drams were provided in December at the average 17.2%, up from 17.1% in November, while loans foreign currency loans at 15%, up from 14% in November. ($1 – 388.37 drams). -0-

spot_img

POPULAR

Armenia’s public debt will remain stable at just above 40% in the medium term – S&P

Armenia's public debt (excluding liquid assets) will remain broadly stable at just above 40% of GDP in the medium term, according to a report from the international rating agency S&P Global Ratings.

S&P: Armenia’s banking sector is well capitalized and highly profitable

Armenia's banking sector remains well capitalized and highly profitable, supported by high net interest income and robust economic growth, according to a report from international rating agency S&P Global Ratings.

Armbanks Weekly Digest: Key Events in the Armenian Financial Market (August 17–23)

Key developments in Armenia's financial market this week included new banking compliance requirements, measures against account fraud, and decisions related to capital market development.

The investment portfolio of Armenian banks in the second quarter amounted to 1.93 trillion drams, a decline of 9.5% year-to-date

The total investment portfolio of commercial banks in Armenia at the end of June 2026 amounted to 1,933,341,220 thousand drams, a decrease of 202.38 billion drams, or 9.48%, year-to-date.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img